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ABSTRACT

ARTICLE HISTORY

Purpose of the study: Macular pigment (MP), comprising the dietary carotenoids lutein, zeaxanthin and
meso-zeaxanthin, is believed to benefit eye health and vision. Numerous clinical and research devices and
techniques are currently available to facilitate MP optical density (MPOD) measurement. One of those
techniques, dual-wavelength fundus autofluorescence (AF) is being increasingly used for measurement of
MP in the eye. There is substantial methodological variation across the published studies that have
employed this technique, including in relation to the use of mydriasis, the possible influence of which
does not appear to have been addressed in the literature. This prospective cross-sectional study was
designed to investigate the effect of mydriasis on MP measurement quality and MPOD values obtained
with dual-wavelength AF using the Heidelberg Spectralis HRA+OCT device.
Materials and Methods: Twenty-one healthy participants were recruited to the study. The mean age of
participants was 44.8 years (± 14.63). Pupil size and MPOD were measured in one eye for each participant,
initially under natural pupil conditions and subsequently 30 minutes following instillation of one drop of
0.5% tropicamide.
Results: Despite providing MPOD measurements for the majority of undilated eyes (85.7% of eyes herein),
pupillary dilation resulted in statistically significant changes in MPOD (p < .001 for central eccentricities).
Our results indicate that the changes in MPOD were not uniform across the spatial profile. Marked
improvements were also observed in image quality post-dilation (p < .002 for central eccentricities).
Conclusions: This study clearly demonstrates that dual-wavelength AF measurements of MPOD in the
same eye vary as a function of pupillary dilation status, with MPOD under-estimated across the entire
spatial profile of MP for natural relative to dilated pupillary conditions. Mydriasis should, therefore, be
used routinely for MPOD measurements using dual wavelength AF, pupil size should be reported and
image quality optimized in order to ensure accurate MPOD quantification.
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Introduction
Macular pigment (MP) is composed of the three dietary car
otenoids: lutein (L), zeaxanthin (Z), and meso-zeaxanthin
(MZ) which accumulate selectively in the retina, giving the
macula lutea its characteristic yellow appearance. MP’s consti
tuent carotenoids possess short-wavelength light-filtering,
antioxidant, anti-inflammatory, and neuro-protective proper
ties, which are believed to benefit eye health and vision.1,2
L and Z are also found in several specific regions in the brain
including the frontal, occipital, and temporal cortices, hippo
campus, and cerebellum.3–6 Studies have demonstrated that
MP can be augmented by supplementation or by incorporating
more carotenoid-rich food into the diet.7,8 MP and its consti
tuent carotenoids have been studied extensively for their role in
eye health and in the prevention of retinal disease such as agerelated macular degeneration and, more recently, conditions
such as diabetes and glaucoma.9–11 There is also a limited body
of research exploring the role of MP for cognitive health.12–14
To study the role of MP for ocular and cognitive health, a valid
measure of MP in the eye is required.

KEYWORDS

Macular pigment; dualwavelength
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Heterochromatic flicker photometry (HFP) is accepted as
the gold standard for measurement of MPOD.15,16 However,
HFP requires good vision and is reliant on participants to
follow detailed instructions, sustain concentration, and fixation
over an extended period. MPOD can, therefore, prove difficult
to measure using the HFP technique, particularly in older
participants with ophthalmic disease such as glaucoma.9,17 It
also takes considerable time to obtain MP data at sufficient
retinal eccentricities to build up a spatial profile of MPOD
using HFP.
Dual-wavelength fundus autofluorescence (AF) is less
widely used, but provides a non-psychophysical method of
measuring MPOD based on detection of the fluorescence
derived from lipofuscin.18 The technique requires minimal
participation by the subject, who is required only to fixate on
an internal target within the system for 30 seconds. Dualwavelength AF has been shown to achieve reliable and repro
ducible measures of MPOD.19,20 This technique provides an
additional benefit as it measures the entire spatial profile (see
Figure 1) and volume of MP (compared to the isolated single
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Methods

Figure 1. Example of MP Spatial profile output obtained with dual-wavelength
autofluorescence using the Heidelberg Spectralis® HRA + OCT Multicolor
(Heidelberg Engineering GmbH, Heidelberg, Germany) for undilated (left) and
dilated (right) conditions in the same eye. Note: retinal eccentricity is provided on
the X-axis and MPOD on the Y-axis. MPOD is indicated by the central dark thin line
located in the middle of the green zone. The width of the green zone provides a
visual indication of the standard deviation of the measures on MPOD at each
eccentricity (no quantitative data are provided as to the size of the standard
deviation). A wider green zone indicates greater standard deviation in the MPOD
measurement, equating to a poorer quality measure. The blue bars above and
below the green zone provide the minimum and maximum MPOD values mea
sured at each eccentricity (again, no quantitative output is given as a measure of
this minimum and maximum value, just the visual representation).

points measured by HFP). Although the device required for
dual-wavelength fundus AF measurement is significantly more
expensive than HFP, this technique provides more information
regarding the complete spatial profile of MPOD at any single
measurement, and enhanced capacity to detect any change
across this profile in response to temporal variation in dietary
intake, supplement use, or disease status.
Dual-wavelength AF measurements of MPOD in healthy
participants have been shown to demonstrate good agreement
with measurements using HFP,20 customized HFP,19 and
a dual-wavelength reflectance technique.20 Additionally,
MPOD measured with this method appears to correlate well
with serum L and Z, and with skin carotenoid levels.21 It has
been previously reported, however, that cataract may result in
underestimated MPOD when using AF,22,23 so it would seem
prudent to account for cataract status in dual-wavelength AF
measurements of MPOD. Dual-wavelength AF has also been
demonstrated to be capable of detecting change in MPOD
following supplementation.24–26
The possible influence of pupil size on MPOD measurement
using dual-wavelength AF does not appear to have been
addressed in the literature. In most cases, it is possible to
measure MPOD under natural un-dilated pupil conditions,
even though the measurement requires exposure to an intense
light source. Although pupillary dilation is generally accepted
as a methodological requirement for MPOD measurement
using dual-wavelength AF, a review of the available literature
reveals numerous published studies that do not report using
mydriatic eye drops to dilate the pupil before MPOD measure
ment with this technique.24,27–31 Moreover, even in studies that
report dilating for dual-wavelength fundus AF MPOD mea
surement, specific detail such as the actual pupil size following
dilation is not typically provided.32–34 Importantly, only three
of the (circa 100) studies that we reviewed, reported using
a measure of MPOD image quality, a feature which is not
provided inherently by the device.19,22,35

This prospective cross-sectional study was designed to investi
gate the effect of mydriasis on MP measurement quality and
MPOD values obtained with dual-wavelength AF using the
Heidelberg Spectralis HRA+OCT MultiColor (Heidelberg
Engineering GmbH, Germany).
Twenty-one healthy subjects without retinal pathology or
cataract were recruited into the study. The mean age of parti
cipants was 44.8 years (± 14.63), with a range from 27 to
70 years.
A comprehensive ocular examination was conducted to
determine eye health, including a review of ocular and medical
history, distance monocular visual acuity (VA) using ETDRS
chart with participant’s spectacles, slit lamp, and Volk lens
examination, intraocular pressure measurement with the
Icare ic100 tonometer, fundus imaging, and glaucoma module
assessment using the Spectralis HRA+OCT device. The eye
with better VA was selected as the study eye. All subjects had
good vision, with a mean LogMAR visual acuity in the study
eye of −0.12 (± 0.1) (Snellen equivalent 6/5 + 1).
The study was explained to each participant before obtain
ing written informed consent. The study was approved by the
Research Ethics and Integrity Committee at Technological
University Dublin (TU Dublin) and conformed to the tenets
of the Declaration of Helsinki.

Order of procedures
First, minimum pupil size was measured using the Aladdin
optical biometer (Topcon, Tokyo, Japan). Immediately after
this, the first MPOD measurement was obtained using the
Spectralis device. The study eye was then dilated with one
drop of 0.5% tropicamide (Bausch + Lomb, Surrey, United
Kingdom). After 30 minutes, a second set of pupillometry
and MPOD measurements were captured. All measurements
were obtained by the same examiner (EL).

Minimum pupil size measurement
The Aladdin biometer uses white light-emitting diodes (LEDs)
to produce photopic light conditions and to constrict the pupil.
Minimum pupil diameter was automatically measured using
dynamic pupillometry. Pupil size was measured in a darkened
room (lux levels at the eye when using the Aladdin device:
<0.01 lux). Pupil size was recorded continuously for 20 seconds
following exposure to a 0.4 mW bright LED flash. A graph of
pupil size over time was plotted and minimum pupil size was
recorded automatically as the lowest recorded size (typically
reached within one to two secondspost flash).

MPOD measurement
MPOD was measured using a dual-wavelength AF method, as
described previously,36,37 using the Heidelberg Spectralis. This
device uses a confocal scanning laser ophthalmoscope (cSLO)
and two excitation wavelengths (486 nm [blue light which is
well absorbed by MP] and 516 nm [green light, absorption of
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which by MP is low]). The light intensity of the green and blue
diode lasers in the Heidelberg Spectralis device is 0.44 mW.
AF images of the 30° central area of the retina were recorded
for both wavelengths and foveal fluorescence was compared
with a parafoveal reference point set at 6° retinal eccentricity.
MP density maps were then computed by the Heidelberg Eye
Explorer software (HEYEX, version 1.9.13.0) by analyzing the
AF images obtained at both wavelengths. As absorption of MP
at 486 nm is high, and at 516 nm is close to zero, and there is
virtually no MP in the parafoveal region that is used as
a reference, total MP and its spatial profile could be determined
(Figure 1).
MPOD measurements were obtained in a darkened room
(lux levels at the eye when using the Spectralis device: 1 lux).
After ensuring the correct positioning of the participant’s head
against the chin- and headrest, the AF mode was activated by
switching the lever on the camera head to the vertical down
position. The acquisition panel was then turned on, after which
alignment, focus, and illumination were optimized in reflected
infrared mode (IR). Then, IR mode was switched to blue AF +
green AF (BAF+GAF) mode. Focus and image brightness were
readjusted in the BAF+GAF mode. Subjects were advised that
they could blink if necessary. After at least 15 seconds of retinal
bleaching, sequences of images were captured (recorded as
a 30 second movie), which were then processed using an
averaging technique by the Spectralis device. MP plots with
MPOD values for circles centered on the fovea were automa
tically generated.
MPOD volume at 6° retinal eccentricity as well as MPOD at
0.23, 0.51, 0.74, 0.98, 1.25, 1.48, 1.76, 1.99, 2.5, 3.01 degrees
retinal eccentricity were obtained from the resulting MPOD
plots. In addition, standard deviations (SDs) of MPOD at three
eccentricities (0.23, 0.98, and 1.99) the green bars on Figure 1
were read from the plots using an open-source graph reader
(graphreader.com). SDs at the three retinal eccentricities were
used as an indicator of image quality.
Statistical analysis was performed using the SPSS statistical
software package, V.24.0 (IBM-SPSS, Chicago, Illinois, USA).
Figures were produced using the Microsoft R Studio package
for Windows (R Core Team, 2019).38

Results
Undilated AF images with acceptable quality for MP calcula
tion could be obtained for 18 subjects. In three subjects

(14.3%), two attempts at capturing dual-wavelength AF video
were made, but resulted in images that could not be processed
by the device software. Successful measurements of MPOD
were obtained for all 21 participants post-dilation. A marked
improvement in image quality features (including SD, mini
mum and maximum values) was observed for every participant
across the entire spatial profile of MP under dilated pupillary
conditions (Figure 1).
Statistical analysis was performed on the 18 eyes of 18
subjects with available pre- and post-mydriasis MPOD and
pupillometry measurements.

MPOD, SD and minimum pupil size
A paired samples t-test was conducted to compare MPOD
volume, individual MPOD measurements at four commonly
reported central eccentricities, minimum pupil size, and SD
values at three selected eccentricities pre- and post-mydriasis.
Pre-dilation measures of minimum pupil size, MPOD at all
eccentricities, MPOD volume, and all SDs were statistically
significantly different from those obtained post-dilation even
after Bonferroni correction for multiple testing (pairedsamples t-test, p ≤ 0.002 for all). Of note, SD values were
substantially higher pre-mydriasis in every participant, with
the mean SD between 2.2 and 2.8 times higher at the measured
eccentricities under natural pupil conditions. The detailed preand post-dilation pupil size, SD, and MPOD data at commonly
reported eccentricities are presented in Table 1. All data apart
from SDs were normally distributed. To account for the nonnormal distribution of the SD data, Spearman’s correlationranked order was used.
Figure 2 shows the spatial profile of mean MPOD for undi
lated (red) and dilated (green) pupils 30 minutes after instilla
tion of tropicamide 0.5%. A repeated measures mixed ANOVA
was conducted including the factors dilation status (undilated
and dilated) and eccentricities (0.23°, 0.51°, 0.74°, 0.98°, 1.25°,
1.48°, 1.76°, 1.99°, 2.5°, 3.01°). A statistically significant effect of
dilation status (F (1,17) = 73.134, p < .001) and eccentricity (F
(9,153) = 163.619, p < .001) and a statistically significant inter
action of dilation status and eccentricity (F (9,153) = 9.282,
p < .001) was detected. Figure 2 illustrates the systematically
higher MPOD values obtained following pupil dilation across
the entire spatial profile of MP. The mean change in MPOD is
not uniform however, with the highest level of change observed
centrally (~20% for the two most central eccentricities), while

Table 1. Minimum pupil size, MPOD, and SD data before and after mydriasis.
Parameter
Minimum pupil size
MPOD, mean
0.23°
0.51°
0.74°
0.98°
Volume, at 6°
MPOD plot SD 0.23†
MPOD plot SD 0.98†
MPOD plot SD 1.99†

Undilated (mean ± SD)
3.22 ± 0.64

Dilated (mean ± SD)
5.5 ± 0.88

t (17)
−9.953

P value
< 0.001

0.38 ± 0.08
0.31 ± 0.09
0.32 ± 0.09
0.28 ± 0.08
3928.29 ± 2035.65
0.17 ± 0.1
0.13 ± 0.07
0.11 ± 0.07

0.46 ± 0.08
0.37 ± 0.1
0.37 ± 0.09
0.31 ± 0.08
4884.43 ± 2133.28
0.06 ± 0.02
0.06 ± 0.03
0.04 ± 0.02

−5.2
−5.477
−4.593
−5.394
−11.529
4.811
3.908
4.682

< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001

P-value obtained using the paired samples t-test and a Wilcox Rank Sum test for the SD data. Minimum pupil size under bright illumination (light
intensity 0.4 mW). †SD – standard deviation as derived from the green bars on MPOD plots.
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Figure 2. Mean and standard error of the spatial profile of MPOD across the
central 3°, for undilated (red) and dilated (green) 30 minutes after instillation of
tropicamide 0.5%. Insert – Subtraction of undilated from dilated MPOD at each
retinal eccentricity.

the difference is relatively consistently lower at more peripheral
eccentricities. The statistically significant interaction between
dilation and eccentricity is illustrated in the plot of the sub
traction of dilated and undilated MPOD at each retinal eccen
tricity (insert of Figure 2).
Image quality and its relationship to pupil size
Figure 3 illustrates a marked reduction and compression of
MPOD SD values, reflecting the improvement in image quality
of the MPOD measurement following dilation for three indi
cative retinal eccentricities (0.23°, 0.98° and 1.99°).
To investigate the effect of dilation and eccentricity on the SD
of MPOD, a repeated measures mixed ANOVA was conducted
with the factors being dilation status (undilated, dilated) and
eccentricities (0.23, 0.98, 1.99). A statistically significant effect of
dilation status (F (1,17) = 18.114, p = .001) and eccentricity (F

Figure 3. Boxplot and individual subject data of standard deviation of MPOD
measurement at 0.23°, 0.98° and 1.99° for undilated (red) and dilated (green)
measurements.
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(2,34) = 15.859, p < .001) and an interaction of dilation status
and eccentricity was observed (F = 8.395, p = .009).
A linear regression was calculated to investigate the SD mea
sures obtained from the MP graph at 0.23° retinal eccentricity as
a function of pupil size and to determine a cut-off value for
acceptable MPOD measurement quality. The simple linear regres
sion showed a significant relationship between SD measures
obtained from the MP graph at 0.23° retinal eccentricity as
a function of minimum pupil size (F (1,34) = 15.64, p < .001).
The slope coefficient for pupil size was −0.03711 (t (34) = −3.995,
p < .001) with the intercept of 0.274813 (t (34) = 6.412, p < .001).
The R2 value was 0.3151 so 31.5% of the variation in the SD of
MPOD was explained by the model containing pupil size. This
model gives the formula of (SD of MPOD) = −0.037 (Pupil size) +
0.274813.
An unsupervised k-means cluster analysis was conducted to
categorize two clusters by minimum pupil size and SD mea
sures obtained from the MP graph at 0.23° retinal eccentricity.
A scatter plot of each subjects SD of MPOD at 0.23° as
a function of pupil size and dilation status was produced with
subject data assigned to a classification cluster. The analysis
resulted in the classification of two equal groups of 18, the first
cluster contained 17 of the 18 participants post-dilation with 1
participant misclassified. In the second cluster, 17 of the 18
participants were classified as undilated with 1 participant
misclassified (Figure 4). The unsupervised analysis resulted in
a 94.4% accuracy of classification. The pupil size of 4.35 mm
indicated by the vertical-dashed blue line which corresponds to
the midpoint between cluster 1 and cluster 2 (Figure 4). Using
the linear regression equation derived above, a 4.35 mm pupil
size yields a predicted SD value of 0.11 which could be used as
a cut-off value for acceptable MPOD measurement quality.

Discussion
This study provides comprehensive evidence that pupil size is
an important consideration in the measurement of MP using

Figure 4. Scatter plot showing relationship between minimum pupil size and SD
of the MPOD at 0.23° retinal eccentricity. Green (dilated) and red (undilated)
colors indicate pupil dilation status for each subject; blue line indicates the
bisection line; the triangle and circle symbols indicated which k-means classifica
tion cluster the subject data was assigned to.
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the Spectralis dual-wavelength fundus AF device. Despite pro
viding MPOD measurements for the majority of undilated eyes
(85.7% of eyes herein), two critical observations can be made in
relation to the impact of mydriasis. First, larger pupils facilitate
better quality MPOD measures, evidenced by the tighter SDs
(note the shorter green bars visible in Figure 1) and narrower
range (note the variation in blue bars in Figure 1) observed
post-dilation. This improvement in image quality and capacity
to measure MPOD is not surprising given that the intensity of
the stimuli used would cause a strong miotic response under
natural pupillary conditions. Second, and perhaps more
importantly, MPOD measurements in the same eye vary as
a function of pupillary dilation status, with MPOD invariably
under-estimated across the entire spatial profile of MP for
natural relative to dilated pupillary conditions.
Dual-wavelength fundus AF is being increasingly used for
the determination of ocular MPOD levels as it offers distinct
benefits over other techniques. The time required to capture
MPOD measurements is substantially reduced compared to
psychophysical techniques so participant fatigue is no longer
a measurement consideration.39 Additionally, it provides much
more detailed information on the spatial profile of MP and the
graphical output is clinically useful,40 particularly in relation to
the evaluation of MPOD change over time. Of note, although
Spectralis gathers clinically useful information on the entire
special profile of MP, the density of carotenoid deposits
decreases rapidly at extrafoveal eccentricities, which leads to
increased variability in peripheral MP measures. Analysis of
individual data points should, therefore, prioritize central MP
measures including for the assessment of quality indices.
The measurements have proven to be relatively robust in
terms of reproducibility over time in the absence of cataract.20
Good within-session repeatability has also been shown,
although a higher coefficient of repeatability for MPOD mea
sures inside 0.1° of retinal eccentricity has prompted the sug
gestion to capture multiple MPOD measures to ensure robust
values.41 Dual-wavelength AF devices used to measure MPOD
are not generally commercially available to clinicians, so there
are no practical guidelines available regarding a standardized
method of measurement. Additionally, although the
Heidelberg Spectralis provides a detailed graphical representa
tion of the MPOD measurement, it does not provide any
quantitative index of image quality or measurement accept
ability. Although the differences in Figures 1 and 3 are marked,
there is nothing in the measurement output to indicate at what
point an acceptable level of quality has been achieved. Given
the variation in MPOD values obtained under the two condi
tions, analysis of the graphical outputs to determine measure
ment acceptability would seem prudent.
In a clinical environment, it would be highly beneficial to
avoid the necessity for dilation. Time and cost savings would
benefit practitioners, patients would save time too and would
avoid the short-term quality of life impact of dilation on visual
comfort and performance. It could be argued that these bene
fits might outweigh a slight underestimation of MPOD. The
level of underestimation in natural pupillary conditions was
not consistent, however, either between participants or across
the spatial profile of MP within participants. The difference in
MPOD volume following dilation, for example, ranged

between 263.61 and 1523.54 units of optical density volume.
Moreover, the profile of MP overall was also different in preand post-mydriasis measurements. As illustrated in Figure 2,
the profile of MP for undilated measurements appears flattened
centrally relative to the periphery, not showing the full extent
of the peak MPOD as observed in dilated conditions. The
statistically significant interaction between dilation and eccen
tricity as illustrated on the insert in Figure 2 would suggest that
any correction factor would need to incorporate retinal eccen
tricity as a means to adjust MPOD based on undilated
measurements.
From a research perspective, our analysis of the methodo
logical approach adopted in the published literature involving
dual-wavelength AF for MPOD measurement reveals substan
tial variation between studies and, in many cases, insufficient
detail to determine the validity of the MPOD findings. The lack
of standardized approach to the measurement creates difficulty
in relation to the interpretation of the relative findings reported
across the various studies and may even invalidate the out
comes of some.
This is not the first study to demonstrate differences in
MPOD measurements associated with the quality of measure
ment taken. The presence of cataract has also been shown to
cause an underestimation of MPOD when measured using
dual-wavelength AF by comparing MPOD levels pre- and postcataract surgery.22 It appears that the magnitude of difference
in MP values was much higher (approximately 5 times higher)
between then pre- and post-cataract measurements (0.26 opti
cal density units at 0.51° retinal eccentricity and 4.452 optical
density units for volume at 8.98°) when compared to the preand post-mydriasis measurements in the current study (0.059
optical density units at 0.51° retinal eccentricity and 956.14
optical density units for volume at 8.98°). Also baseline mea
surements could not be obtained for a higher percentage of
participants in the cataract study (33% compared to 14.3% in
our study). This suggests that the effect of cataract on measure
ment is a lot more pronounced than that of the pupil size.
Statistically significant variation of MP, however, was observed
through all of the central eccentricities analyzed. The image
quality index (IQI) calculated in the cataract study is very
specific to cataract and therefore not useful in its current
format for more general use.22
The protocol adopted herein, to measure MPOD 30 minutes
after instillation of 0.5% tropicamide, was sufficient to allow
a high degree of classification accuracy in our cluster analysis
without any other assumptions. Dilated pupils tended to be
larger than 4 mm under bright light stimulation (in 96% of
cases, with the other one case just below 4 mm), which deliv
ered statistically significantly better image quality according to
the computed SDs (mean SD values for dilated pupils ranged
from 0.04 to 0.1). The 4 mm finding is entirely consistent with
the optical set up of the dual-wavelength AF device. The
incident blue and green laser beams intercept the pupil plane
in a 1–2 mm diameter spot. The emitted AF is captured by the
entrance pupil (detection system), which has a diameter of
4 mm. Thus, if the pupil is less than 4 mm, less light will be
available for analysis, and noise will increase. The blue light
image in the fovea (lowest fundus AF) may reach levels of nonlinear behavior with increased noise levels. The green light
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image and more peripheral sites at both wavelengths will be
less affected because the AF is larger, hence leading to the
observed underestimation of MPOD and variation in degree
of underestimation across its spatial profile. On the basis of
these outcomes, we would suggest that future studies consider
implementation of a standardized methodological approach to
MPOD measurement using dual-wavelength AF. This
approach should include sufficient mydriasis to allow
a minimum pupil size greater than 4 mm under intense bright
light stimulation. The methodological approach should also be
more comprehensively described. Additionally, the reporting
of MPOD should include a quality metric such as the SD values
reported herein, and consideration given to the rejection of
MPOD values that do not meet SD criteria. In our study, for
minimum pupil size under bright illumination conditions of
over 4 mm, SD values at 0.23° eccentricity ranged from 0.04 to
0.1. Using the linear regression equation, the 0.13 predicted SD
value at 0.23° eccentricity for a pupil size of 4 mm may provide
a reasonable cut-off value for acceptable MPOD measurement
quality (SD values were typically lower more peripherally).
Limitations
One of the limitations of this study is that pupil size and
MPOD are measured using two different devices and there
was a short time gap between conducting pupillometry and
measuring MPOD. The light intensity in the Spectralis device is
higher than that used in the Aladdin device, so that the mini
mum pupil size during MPOD measurement could be slightly
smaller than that recorded using Aladdin. Another limitation is
the relatively small sample size, as the undilated measurement
could be obtained only for 18 subjects. However, the sample
size was sufficient to show highly statistically significant differ
ences between pre- and post-dilation MPOD and SD values
across the spatial profile of MP, and allowed the estimation of
the suggested cut-off point for pupil size and quality of mea
surement. One final possible limitation relates to the use of
0.5% tropicamide as the mydriatic agent. Most studies that
have reported the type of mydriatic agent used have employed
tropicamide plus phenylephrine, or if used alone, a more
potent 1% tropicamide concentration. Although it might be
perceived as a limitation, the use of the lower 0.5% concentra
tion herein was deliberate for two reasons. First, the lower
concentration offers benefits in terms of the lesser and shorter
duration quality of life impact on study participants and
patients in clinical practice. Second, and more importantly, it
was implemented as a means to determine whether any effects
observed might relate to the degree of mydriasis induced. The
use of the 0.5% concentration resulted in a broad range of postdilation pupil size from just under 4 mm to over 7 mm. It was
felt that a higher concentration may cause a greater average
increase in pupil size but narrower overall range. Figure 4
demonstrates very clearly the absence of any relationship
between the measurement SD and pupil size post-dilation
despite the more than 3 mm range of pupil size. As such, this
study demonstrates that measurement quality is essentially
independent of the type of mydriatic used once sufficient
mydriasis is induced to yield a minimum photopic pupil dia
meter of no less than 4.35 mm.
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Of note, pupil size in the current study was measured using
an automated pupillometer. However, it has been shown that
there is no significant disagreement between manual and auto
mated pupillometer measurements, so the suggestions for
pupil size presented in the current study can be applicable to
both automated and manual pupil size measurements.42

Conclusions
In conclusion, this study confirms that pupillary dilation is
required for accurate measurement of MPOD when using the
dual-wavelength AF technique, and reinforces that the mea
surement protocol should include confirmation that pupil size
exceeds the entrance pupil size of the device (in this case 4 mm)
under intense bright light stimulation. Although the
Heidelberg Spectralis device does not provide a quantitative
indicator for the MP measurement quality, SD values at each
retinal eccentricity indicative of image quality can be extracted
from the graphical output. Our data indicate that a cut-off SD
value at 0.23° retinal eccentricity of 0.11 may provide a simple
clinical guide to ensure optimal image quality. Numerous
published studies do not report using mydriatic eye drops to
dilate the pupil before MPOD measurement, or omit specific
detail such as the actual pupil size following dilation with this
technique.24,27-31 Future publications should, therefore, pro
vide more specific detail on the treatment of pupils and the
resultant quality metrics obtained in the respective studies to
allow more complete and accurate assessment of the reported
findings.
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